Cost-Effectiveness of Extended-Release Methylphenidate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder Sub-Optimally Treated with Immediate Release Methylphenidate

BACKGROUND: Attention-Deficit/Hyperactivity Disorder (ADHD) is a common psychiatric disorder in children and adolescents. Immediate-release methylphenidate (IR-MPH) is the medical treatment of first choice. The necessity to use several IR-MPH tablets per day and associated potential social stigma at...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Schans, Jurjen, Kotsopoulos, Nikos, Hoekstra, Pieter J., Hak, Eelko, Postma, Maarten J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449164/
https://www.ncbi.nlm.nih.gov/pubmed/26024479
http://dx.doi.org/10.1371/journal.pone.0127237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449164/
https://www.ncbi.nlm.nih.gov/pubmed/26024479
http://dx.doi.org/10.1371/journal.pone.0127237

Ejemplares similares